ClinVar Miner

Submissions for variant NM_000419.5(ITGA2B):c.1520C>G (p.Pro507Arg)

dbSNP: rs2143461368
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen RCV001803418 SCV002047569 uncertain significance Glanzmann thrombasthenia 2024-09-05 reviewed by expert panel curation The ITGA2B missense variant NM_000419.5:c.1520C>G replaces the proline residue with an arginine residue (p.Pro507Arg). This variant has been observed in homozygosity (PM3_supporting) in one individual with a phenotype specific for Glanzmann's thrombasthenia (GT) (GT43, PMID: 16463284). All requirements for PP4_moderate are met (GT43 in PMID: 16463284): history of bleeding and impaired aggregation to at least two agonists, but normal or only mildly reduced agglutination with ristocetin. This variant is absent from gnomADv4.1.0 (PM2_supporting). The in silico meta-predictor REVEL score for this variant is 0.224, below the VCEP-established threshold of <0.25 and suggestive of no damaging effect on protein function (BP4). In summary, this variant is of uncertain significance and lacks sufficient evidence to be classified as pathogenic or benign for GT. GT-specific criteria applied: PP4_Moderate, PM2_Supporting, PM3_Supporting, and BP4.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.